Asia Pacific Biomaterials Market worth $15.12 billion by 2030
The report "Asia Pacific Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030" is projected to grow from USD 10.39 billion in 2025 and to reach USD 15.12 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Browse 550 market data Tables and 45 Figures spread through 450 Pages and in-depth TOC on "Asia Pacific Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-biomaterials-market-265050118.html
The Asia Pacific biomaterials market is growing due to factors such as the rapid expansion of healthcare infrastructure, increasing healthcare expenditures, and a rising prevalence of chronic diseases, trauma, and age-related conditions in the region.
The metallic biomaterials segment accounted for the largest share of the Asia Pacific biomaterials market in 2024.
Based on type, the biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver, magnesium, and other metallic biomaterials), polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, and other polymeric biomaterials), ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon, and glass), and natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, and other natural biomaterials). The metallic biomaterials segment accounted for the largest share of the Asia Pacific biomaterials market in 2024. The large share of this segment is primarily attributed to the extensive use of metals in the manufacturing of medical devices, including those for cardiovascular, dental, and orthopedic applications. Additionally, the increasing geriatric population worldwide is anticipated to drive demand for these devices, as older individuals typically have a higher need for assistance due to their vulnerability to orthopedic, dental, ophthalmologic, neurological, and cardiovascular diseases.
The orthopedic segment accounted for the largest share of the Asia Pacific biomaterials market in 2024.
The Asia Pacific biomaterials market is segmented by application into orthopedic, cardiovascular, dental, plastic surgery, urinary applications, wound healing, tissue engineering, ophthalmology, neurological/central nervous system, and other applications. In 2024, the orthopedic segment accounted for the largest share of the Asia Pacific biomaterials market. The demand for surgical procedures is primarily driven by the increasing elderly population, high rates of urbanization, and improved access to surgical care, particularly in high-volume countries like China, Japan, India, and South Korea. There is a growing need for hip replacements, knee replacements, spinal surgeries, and trauma fixation as healthcare systems respond to the rising incidence of age-related diseases, traffic accidents, and occupational musculoskeletal disorders.
China accounted for the largest share of the Asia Pacific biomaterials market in 2024.
China accounted for the largest share of the Asia Pacific biomaterials market. The growth of this market is largely driven by the rapidly expanding device manufacturing industry, a substantial patient base, and supportive government policies, including increased healthcare spending aimed at developing local manufacturing capacity for implants and high-end biomaterials. China’s strengths are further enhanced by its indigenous healthcare reforms, an increase in surgical procedures, and a realignment of investment plans focused on the indigenization of medical technologies. This is particularly evident in the development of orthopedic devices, cardiovascular stents, and dental products. The strengthening of medical device regulations by the National Medical Products Administration (NMPA) and a greater emphasis on clinical data will further promote the use of proven metallic, polymeric, and surface-modified biomaterials.
Key players in the Asia Pacific biomaterials market include BASF SE (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), AMETEK, Inc. (US), Mitsubishi Chemical Group Corporation (Japan), Berkeley Advanced Biomaterials (US), ZEUS Company Inc. (US), and CoorsTek Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Asia Pacific Biomaterials Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
